PALDINO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 3.097
AS - Asia 2.718
EU - Europa 2.240
SA - Sud America 339
AF - Africa 107
OC - Oceania 9
Totale 8.510
Nazione #
US - Stati Uniti d'America 3.016
SG - Singapore 1.055
CN - Cina 650
IT - Italia 608
DE - Germania 326
VN - Vietnam 297
BR - Brasile 247
HK - Hong Kong 238
PL - Polonia 215
KR - Corea 175
NL - Olanda 166
SE - Svezia 160
FR - Francia 142
GB - Regno Unito 142
FI - Finlandia 133
RU - Federazione Russa 89
IN - India 67
IE - Irlanda 56
BG - Bulgaria 46
CA - Canada 46
CH - Svizzera 39
AR - Argentina 33
BD - Bangladesh 33
MA - Marocco 32
TR - Turchia 30
ES - Italia 26
ID - Indonesia 25
JP - Giappone 25
MX - Messico 23
ZA - Sudafrica 23
EG - Egitto 19
IQ - Iraq 19
UA - Ucraina 19
AT - Austria 18
CL - Cile 13
CO - Colombia 12
EC - Ecuador 12
SA - Arabia Saudita 11
PH - Filippine 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
IR - Iran 8
TW - Taiwan 8
AU - Australia 7
BE - Belgio 7
CZ - Repubblica Ceca 7
VE - Venezuela 7
KE - Kenya 6
KZ - Kazakistan 5
LT - Lituania 5
TH - Thailandia 5
GR - Grecia 4
JO - Giordania 4
LB - Libano 4
NP - Nepal 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
KG - Kirghizistan 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
UZ - Uzbekistan 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UG - Uganda 2
BB - Barbados 1
BF - Burkina Faso 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 8.496
Città #
Singapore 630
Ashburn 458
San Jose 259
Hong Kong 217
Chandler 216
Dallas 178
Beijing 164
Warsaw 162
Hefei 160
Seoul 160
Trieste 156
Fairfield 142
Munich 138
Chicago 109
Los Angeles 102
Ho Chi Minh City 91
Helsinki 85
Seattle 83
Boardman 80
Milan 79
Council Bluffs 78
Hanoi 64
London 62
Woodbridge 61
Cambridge 58
Lauterbourg 55
Wilmington 53
New York 52
Santa Clara 52
Dublin 51
Frankfurt am Main 47
Amsterdam 46
Sofia 46
Zgierz 45
Princeton 42
Columbus 37
Houston 37
Moscow 34
Da Nang 27
Lappeenranta 27
Orem 27
Denver 25
Buffalo 24
Casablanca 24
São Paulo 24
Ann Arbor 23
Venice 23
Nuremberg 22
Bern 21
Redondo Beach 20
Rome 19
San Diego 18
Brooklyn 17
Bremen 16
Chennai 16
Washington 16
Düsseldorf 15
Vienna 15
Boydton 14
Jacksonville 14
Salt Lake City 14
Shanghai 14
Tokyo 14
Turku 14
Elk Grove Village 13
Izmir 13
Montreal 13
Münster 13
Stockholm 13
The Dalles 13
Dong Ket 12
Grafing 12
Naples 12
Phoenix 12
Berlin 11
Dearborn 11
Dhaka 11
Florence 11
Haiphong 11
Tampa 11
Giza 10
Toronto 10
Turin 10
Atlanta 9
Redmond 9
Baghdad 8
Bologna 8
Breda 8
Jeddah 8
Johannesburg 8
Poplar 8
Rio de Janeiro 8
San Francisco 8
Santiago 8
Cape Town 7
Genoa 7
Istanbul 7
Jinan 7
Cairo 6
Manchester 6
Totale 5.444
Nome #
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 286
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 282
Chapter 13: Current Management and Treatment 266
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone 245
Genetics of Dilated Cardiomyopathy: Clinical Implications 242
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 240
TITIN DOWNREGULATION AFFECTS CARDIOMYOCYTES PROLIFERATION 236
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 217
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 216
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 213
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 210
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 206
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 205
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 196
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 188
Echocardiographic evaluation of centenarians in Trieste 188
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 169
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 166
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 165
Cardiomyopathies in children: Classification, diagnosis and treatment 158
Myocarditis: Which Role for Genetics? 157
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 157
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 155
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 155
Prognostic role of exercise intensity in familial Filamin C truncating variants 153
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 151
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 147
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 146
Cardiology of the future: xenotransplantation with porcine heart 141
Lymphocytic Myocarditis: A Genetically Predisposed Disease? 141
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 140
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 138
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 136
Focus on arrhythmogenic right ventricular cardiomyopathy 134
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 133
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 128
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence 124
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 121
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 120
Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation 119
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives 119
Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis 118
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 117
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 112
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 110
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 105
Genetic testing in cardiomyopathies: updates and future perspectives 99
Generation of iPSC lines (ICHi001-A, ICHi002-A, ICHi003-A, ICHi004-A) from four patients carrying Titin truncating variants associated with dilated cardiomyopathy 97
The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series 91
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 87
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 80
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 78
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 77
Reply to the letter regarding the article 'Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis' 63
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 58
Titin Cardiomyopathy, Emerging Evidence: More Than A Big Heart 57
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 49
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 47
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 38
What Should a Clinical Cardiologist Know About Cardiogenetics? 30
Predictors of Disease Progression in Patients with Left Ventricular Non-Dilated Cardiomyopathy 16
Significance of common genetic variants associated with non-ischaemic cardiomyopathy in the general population 15
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 12
Totale 8.765
Categoria #
all - tutte 24.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 0 0 0 0 43 8 29
2021/2022357 18 21 62 15 12 30 13 12 35 20 31 88
2022/2023572 39 80 55 86 63 92 4 46 50 10 37 10
2023/2024653 45 23 36 37 46 66 114 80 20 37 88 61
2024/20251.882 52 77 149 123 134 152 142 146 244 262 173 228
2025/20264.499 455 349 612 471 403 376 636 208 484 505 0 0
Totale 8.765